M Murata

Summary

Affiliation: Nagoya University
Country: Japan

Publications

  1. ncbi request reprint Identification and frequency of a new HLA-A allele, A*030104
    M Murata
    Department of Hematology, Nagoya University Graduate School of Medicine, Nagoya, Japan
    Tissue Antigens 65:391-2. 2005
  2. doi request reprint Clinical factors predicting the response of acute graft-versus-host disease to corticosteroid therapy: an analysis from the GVHD Working Group of the Japan Society for Hematopoietic Cell Transplantation
    Makoto Murata
    Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan
    Biol Blood Marrow Transplant 19:1183-9. 2013
  3. doi request reprint Donor cell leukemia after allogeneic peripheral blood stem cell transplantation: a case report and literature review
    Makoto Murata
    Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, 65 Tsurumai, Showa, Nagoya, Aichi 466 8550, Japan
    Int J Hematol 88:111-5. 2008
  4. doi request reprint Cytotoxic T-lymphocyte antigen 4 haplotype correlates with relapse and survival after allogeneic hematopoietic SCT
    M Murase
    Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan
    Bone Marrow Transplant 46:1444-9. 2011
  5. doi request reprint Clinical characteristics of chronic graft-versus-host disease following umbilical cord blood transplantation for adults
    K Sugimoto
    Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan
    Bone Marrow Transplant 41:729-36. 2008
  6. doi request reprint Clinicopathological manifestations and treatment of intestinal transplant-associated microangiopathy
    Y Inamoto
    Department of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya 466 8560, Japan
    Bone Marrow Transplant 44:43-9. 2009
  7. doi request reprint Donor single nucleotide polymorphism in the CCR9 gene affects the incidence of skin GVHD
    Y Inamoto
    Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan
    Bone Marrow Transplant 45:363-9. 2010
  8. doi request reprint A prospective dose-finding trial using a modified continual reassessment method for optimization of fludarabine plus melphalan conditioning for marrow transplantation from unrelated donors in patients with hematopoietic malignancies
    S Terakura
    Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Japan
    Ann Oncol 22:1865-71. 2011
  9. ncbi request reprint Short-term methotrexate could reduce early immune reactions and improve outcomes in umbilical cord blood transplantation for adults
    H Narimatsu
    Department of Hematology, Toyohashi Municipal Hospital, Toyohashi, Japan
    Bone Marrow Transplant 39:31-9. 2007
  10. ncbi request reprint Intestinal thrombotic microangiopathy after allogeneic bone marrow transplantation: a clinical imitator of acute enteric graft-versus-host disease
    T Nishida
    Department of Internal Medicine, Japanese Red Cross Nagoya First Hospital, Nagoya, Aichi, Japan
    Bone Marrow Transplant 33:1143-50. 2004

Collaborators

Detail Information

Publications26

  1. ncbi request reprint Identification and frequency of a new HLA-A allele, A*030104
    M Murata
    Department of Hematology, Nagoya University Graduate School of Medicine, Nagoya, Japan
    Tissue Antigens 65:391-2. 2005
    ..The frequencies of A*030104 and A*0301 including A*030104 in Japanese population (n = 22,360) were approximately 0.013 and 0.40%, respectively...
  2. doi request reprint Clinical factors predicting the response of acute graft-versus-host disease to corticosteroid therapy: an analysis from the GVHD Working Group of the Japan Society for Hematopoietic Cell Transplantation
    Makoto Murata
    Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan
    Biol Blood Marrow Transplant 19:1183-9. 2013
    ..A prospective study is warranted. ..
  3. doi request reprint Donor cell leukemia after allogeneic peripheral blood stem cell transplantation: a case report and literature review
    Makoto Murata
    Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, 65 Tsurumai, Showa, Nagoya, Aichi 466 8550, Japan
    Int J Hematol 88:111-5. 2008
    ..Peripheral blood stem cells might have an advantage in that they are associated with a low incidence of DCL development because PBSCT recipients receive a higher total cell dose than recipients of bone marrow or cord blood cells...
  4. doi request reprint Cytotoxic T-lymphocyte antigen 4 haplotype correlates with relapse and survival after allogeneic hematopoietic SCT
    M Murase
    Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan
    Bone Marrow Transplant 46:1444-9. 2011
    ..As the presence of the C-A-A haplotype reduced relapse risk and improved survival after allogeneic HSCT, this CTLA-4 haplotype may provide useful information for donor selection...
  5. doi request reprint Clinical characteristics of chronic graft-versus-host disease following umbilical cord blood transplantation for adults
    K Sugimoto
    Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan
    Bone Marrow Transplant 41:729-36. 2008
    ..047). These results suggest that chronic GVHD following CBT is mild and has a graft-versus-malignancy effect...
  6. doi request reprint Clinicopathological manifestations and treatment of intestinal transplant-associated microangiopathy
    Y Inamoto
    Department of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya 466 8560, Japan
    Bone Marrow Transplant 44:43-9. 2009
    ..Avoiding intensified immunosuppression that damages vascular endothelium until the resolution of i-TAM may improve transplant outcome...
  7. doi request reprint Donor single nucleotide polymorphism in the CCR9 gene affects the incidence of skin GVHD
    Y Inamoto
    Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan
    Bone Marrow Transplant 45:363-9. 2010
    ..In conclusion, more active homing of CCR9-926AG T cells to Peyer's patches may produce changes in Ag presentation and result in increased incidence of skin GVHD...
  8. doi request reprint A prospective dose-finding trial using a modified continual reassessment method for optimization of fludarabine plus melphalan conditioning for marrow transplantation from unrelated donors in patients with hematopoietic malignancies
    S Terakura
    Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Japan
    Ann Oncol 22:1865-71. 2011
    ..Thus we examined that modified continual reassessment method (mCRM) is applicable for deciding appropriate conditioning of allogeneic BM transplantation...
  9. ncbi request reprint Short-term methotrexate could reduce early immune reactions and improve outcomes in umbilical cord blood transplantation for adults
    H Narimatsu
    Department of Hematology, Toyohashi Municipal Hospital, Toyohashi, Japan
    Bone Marrow Transplant 39:31-9. 2007
    ..6-30%) (P=0.0001), respectively. Short-term MTX could offer one optimal regimen to reduce immune reactions and improve outcomes in CBT...
  10. ncbi request reprint Intestinal thrombotic microangiopathy after allogeneic bone marrow transplantation: a clinical imitator of acute enteric graft-versus-host disease
    T Nishida
    Department of Internal Medicine, Japanese Red Cross Nagoya First Hospital, Nagoya, Aichi, Japan
    Bone Marrow Transplant 33:1143-50. 2004
    ..Differentiating intestinal TMA from acute GVHD is important in patients suffering from severe and refractory diarrhea after BMT...
  11. ncbi request reprint Increased risk for treatment-related mortality after bone marrow transplantation in GSTM1-positive recipients
    S Terakura
    Department of Hematology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan
    Bone Marrow Transplant 37:381-6. 2006
    ..These results suggest that a GSTM1-null genotype in recipients protects against TRM after allogeneic HSCT. Further studies are needed to elucidate a mechanism of increased risk for TRM in GSTM1-positive recipients...
  12. doi request reprint High incidence of graft failure in unrelated cord blood transplantation using a reduced-intensity preparative regimen consisting of fludarabine and melphalan
    H Narimatsu
    Bone Marrow Transplant 41:753-6. 2008
  13. ncbi request reprint Successful second cord blood transplantation using fludarabine and cyclophosphamide as a preparative regimen for graft rejection following reduced-intensity cord blood transplantation
    E Mizutani
    Bone Marrow Transplant 40:85-7. 2007
  14. ncbi request reprint Mutations of N-RAS, FLT3 and p53 genes are not involved in the development of acute leukemia transformed from myeloproliferative diseases with JAK2 mutation
    M Suzuki
    Leukemia 20:1168-9. 2006
  15. ncbi request reprint Immunosuppressive activity of FTY720, sphingosine 1-phosphate receptor agonist: II. Effect of FTY720 and FTY720-phosphate on host-versus-graft and graft-versus-host reaction in mice
    H Kataoka
    Research Laboratory III Immunology, Mitsubishi Pharma Corporation, Yokohama, Japan
    Transplant Proc 37:107-9. 2005
  16. ncbi request reprint Three novel integrin beta3 subunit missense mutations (H280P, C560F, and G579S) in thrombasthenia, including one (H280P) prevalent in Japanese patients
    H Ambo
    School of Medicine, Keio University, Tokyo, 160 8582, Japan
    Biochem Biophys Res Commun 251:763-8. 1998
    ..The identification of three unrelated patients having the same mutation (H280P) suggests that this mutation might be prevalent in the Japanese thrombasthenic population...
  17. ncbi request reprint The YELLOW VARIEGATED (VAR2) locus encodes a homologue of FtsH, an ATP-dependent protease in Arabidopsis
    K Takechi
    Research Institute for Bioresources, Okayama University, 2 20 1 Chuo, Kurashiki, Okayama, 710 0046 Japan
    Plant Cell Physiol 41:1334-46. 2000
    ..Based on the role of FtsH in a protein degradation pathway in plastids, we propose a possibility that VAR2 is required for plastid differentiation by avoiding partial photooxidation of developing chloroplasts...
  18. ncbi request reprint Stroke and platelet glycoprotein Ibalpha polymorphisms
    A Sonoda
    Thromb Haemost 85:573-4. 2001
  19. ncbi request reprint Impact of genetic polymorphisms of 17-hydroxylase cytochrome P-450 (CYP17) and steroid 5alpha-reductase type II (SRD5A2) genes on prostate-cancer risk among the Japanese population
    Y Yamada
    Second Department of Pathology, Mie University School of Medicine, 2-174 Edobashi, Tsu, Mie 514, Japan
    Int J Cancer 92:683-6. 2001
    ..Regarding the A49T polymorphism of SRD5A2, we could not detect the T allele in any of the examined samples. These data suggest a significant association between the CYP17 polymorphism and prostate-cancer risk among the Japanese...
  20. ncbi request reprint Cholesteryl ester transfer protein polymorphism associated with macroangiopathy in Japanese patients with type 2 diabetes
    S Meguro
    Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku ku, Tokyo 160 8582, Japan
    Atherosclerosis 156:151-6. 2001
    ..0136). Logistic regression analysis revealed that the CETP genotype was independently associated with macroangiopathy. The exact mechanism underlying the association remains unknown, but differences in serum CETP levels may be involved...
  21. ncbi request reprint Recurrent giant longitudinal duodenal ulcer with massive hemorrhage in a Helicobacter pylori-negative patient
    M Fujimoto
    Department of Internal Medicine, Miyoshi Prefectural Hospital, Tokushima, Japan
    J Med Invest 48:210-5. 2001
    ..The ulcer was cured by endoscopic hemostasis and repeated blood transfusions. Attention must be paid to Hp-negative post-bulbar duodenal ulcers because of the frequent complications including hemorrhage...
  22. pmc Notch3 gene polymorphism and ischaemic cerebrovascular disease
    D Ito
    Department of Neurology, School of Medicine, Keio University, Tokyo, Japan
    J Neurol Neurosurg Psychiatry 72:382-4. 2002
    ..65, p=0.311). In conclusion, the results indicate that T6746C polymorphism in the intracellular domain of the Notch3 gene is not associated with an increased risk for CVD...
  23. ncbi request reprint Cytotoxic T lymphocyte antigen 4 gene polymorphism confers susceptibility to type 1 diabetes in Japanese children: analysis of association with HLA genotypes and autoantibodies
    N Kikuoka
    Department of Pediatrics, Tokyo Women s Medical University, Daini Hospital, Japan
    Clin Endocrinol (Oxf) 55:597-603. 2001
    ..We examined a CTLA4 polymorphism and its relationship to human leucocyte antigen (HLA) genotypes and autoantibodies for glutamic acid decarboxylase 65 (GAD65) and IA-2 in Japanese children with Type 1 diabetes...
  24. pmc A reduction in the number of peripheral CD28+CD8+T cells in the acute phase of influenza
    S Nabeshima
    Department of General Medicine, Kyushu University Hospital, Higashiku, Fukuoka, Japan
    Clin Exp Immunol 128:339-46. 2002
    ....
  25. ncbi request reprint T-cell therapy targeting minor histocompatibility Ags for the treatment of leukemia and renal-cell carcinoma
    E H Warren
    Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
    Cytotherapy 4:441. 2002
  26. ncbi request reprint Genetic and structural characterization of an amino acid dimorphism in glycoprotein Ib alpha involved in platelet transfusion refractoriness
    M Murata
    Department of Molecular and Experimental Medicine Committee on Vascular Biology, Scripps Research Institute, La Jolla, CA 92037
    Blood 79:3086-90. 1992
    ..These results explain the structural basis of the Siba human alloantigen system and define screening methodologies useful in transfusion medicine to match donor and recipient platelets accordingly...